Skip to Content

Ezetimibe and Atorvastatin Tablets

Last Updated: September 16, 2015
Status: Current

Products Affected - Description

Liptruzet tablet, Merck
10 mg/ 10 mg, unit of use packages of 30 (NDC 66582-0320-30) - discontinued
10 mg/ 10 mg, unit of use packages of 90 (NDC 66582-0320-54) - discontinued
10 mg/ 20 mg, unit of use packages of 30 (NDC 66582-0321-30) - discontinued
10 mg/ 20 mg, unit of use packages of 90 (NDC 66582-0321-54) - discontinued
10 mg/ 40 mg, unit of use packages of 30 (NDC 66582-0322-30) - discontinued
10 mg/ 40 mg, unit of use packages of 90 (NDC 66582-0322-54) - discontinued
10 mg/ 80 mg, unit of use packages of 30 (NDC 66582-0323-30) - discontinued
10 mg/ 80 mg, unit of use packages of 90 (NDC 66582-0323-54) - discontinued

Reason for the Shortage

  • In January 2014, Merck recalled all Liptruzet lots from wholesalers due to packaging defects in the outer laminate foil pouches. 
  • Merck discontinued Liptruzet in June 2016.

Available Products

No presentations are available.

Estimated Resupply Dates

Merck discontinued all Liptruzet presentations in June 2015.

Related Shortages

Updated

September 16, July 23, May 13, March 16, January 12, 2015; November 5, September 10, July 14, May 19, April 7, March 17, February 24, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide